Publicaciones científicas

Buscar publicaciones por autor/a

84

Última

Autores

Altamirano C, De Andrés A, Dorado P, Llerena A, Montes-Mondragón CF, Peñas-Lledó EM, Ramírez R

84

Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital.

Autores

Dorado P, Fricke-Galindo I, Jung-Cook H, Llerena A, López M, Martínez-Juárez IE, Monroy-Jaramillo N, Ortega-Vázquez A, Peñas-Lledó EM, Rojas-Tomé IS

83

Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population.

Autores

Altamirano C, De Andrés A, Dorado P, Llerena A, Montes-Mondragón CF, Peñas-Lledó EM, Ramírez R

82

High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations.

Autores

Borbón A, De Andrés F, Dorado P, Llerena A, Sarmiento AP

81

Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting.

Autores

Diwakar S, Galaviz-Hernández C, Gil JP, Hernández I, Lara-Riegos J, Llerena A, Molina-Guarneros J, Moya GE, Nair S, Peñas-Lledó EM, Rägo L, Ramírez R, Sosa-Macías M, Tarazona-Santos E, Terán E, Verde I

80

Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy.

Autores

Dorado P, Fricke-Galindo I, Jung-Cook H, Llerena A, López M, Martínez-Juárez IE, Monroy-Jaramillo N, Ortega-Vázquez A, Peñas-Lledó EM, Rojas-Tomé IS

79

Farmacogenetica De La Diabetes Mellitus en Latinoamerica: Una Perspectiva Desde La Red Iberoamericana De Farmacogenética. Cap 15.

Autores

Bonilla M, Cuautle P, Llerena A, Molina-Guarneros J, Rodríguez N, Tana L, Terán E

78

Real-world clinical characterization of subjects with depression treated with antidepressant drugs focused on (non-) genetic factors, pharmacokinetics, and clinical outcomes: GnG-PK/PD-AD study.

Autores

Alves G, Falcão A., Fortuna A, Llerena A, Magalhães P

77

Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans.

Autores

Barrantes R, Calzadilla LR, Estévez-Carrizo FE, Grazina M, López M, Moya GE, Peñas-Lledó EM, Ramírez R, Rodeiro I, Rodrigues-Soares F, Sosa-Macías M, Tarazona-Santos E, Terán E

76

Pharmacogenetics and therapeutic drug monitoring of fluoxetine in a real-world setting: A PK/PD analysis of the influence of (non-) genetic factors.

Autores

Alves G, Falcão A., Fortuna A, Llerena A, Magalhães P